InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Discover the full record of transactions filed by CULLEN JAMES, Director. Officer active across 2 companies, notably Avinger Inc. Cumulatively, 7 disclosures have been logged. Total volume traded: €2.4m. The latest transaction was disclosed on 18 March 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
01,626 shares0
Common Stock
SEC:0001601046-22-000026:0·
€1m7,000 shares@ €174.07440.0039% mcap100.0% of flow
Common Stock
SEC:0001601046-21-000194·
€1m7,000 shares@ €174.07440.0039% mcap50.0% of flow
Common Stock
SEC:0001601046-21-000194:0·
€93184 shares@ €0.504784.0% of flow
Common Stock
SEC:0001437749-21-027580·
€93184 shares@ €0.504742.0% of flow
Common Stock
SEC:0001437749-21-027580:0·
€1832 shares@ €0.551416.0% of flow
Common Stock
SEC:0001437749-21-027434·
€1832 shares@ €0.55148.0% of flow
Common Stock
SEC:0001437749-21-027434:0·
7 of 7 declarations
About CULLEN JAMES
James Cullen is a Director at Avinger Inc and Keysight Technologies, Inc. He plays a key role in the governance of these companies and in strategic decision-making. Avinger specializes in medical technologies, while Keysight Technologies is a leader in test and measurement solutions. James's experience is an asset to these organizations.
